GlassScriptPhysician profile
Arthur W Hammer
NPI 1528060324
$7,678.19
in general payments reported to CMS, 2019-2025
23 companies · $15.31 in 2025
The $15.31 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,342 · 2020: $1,015 · 2021: $1,125 · 2022: $1,189 · 2023: $1,396 · 2024: $596 · 2025: $15.31.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,008.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,007.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,970.14 | 2019-2024 | Trelegy Ellipta, Nucala |
| Astrazeneca Pharmaceuticals LP | $1,889.66 | 2019-2024 | Tezspire, Fasenra, Breztri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $961.60 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $641.50 | 2019-2024 | Dupixent |
| Genentech USA, INC. | $450.41 | 2019-2022 | |
| Genzyme Corporation | $449.68 | 2019-2024 | |
| Optinose US, INC. | $378.58 | 2019-2020 | |
| Advanced Respiratory, INC | $367.38 | 2019-2021 | |
| Pfizer INC. | $97.45 | 2019 | |
| Philips North America LLC | $74.56 | 2019-2022 | |
| Mylan Specialty L.P. | $66.61 | 2021-2022 | |
| Electromed, INC. | $64.32 | 2019-2021 | |
| Amgen INC. | $57.09 | 2022-2023 | Tezspire |
| Merck Sharp & Dohme LLC | $36.17 | 2023 | |
| Actelion Pharmaceuticals US, INC. | $27.23 | 2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harmony Biosciences LLC | $25.53 | 2023 | Wakix |
| Janssen Pharmaceuticals, INC | $23.89 | 2019 | |
| Baxter Healthcare | $19.59 | 2023 | Hillrom - Life 2000 Ventilation System |
| E.R. Squibb & Sons, L.L.C. | $18.93 | 2019 | |
| Circassia INC. | $16.25 | 2019 | |
| Abbvie INC. | $15.31 | 2025 | |
| Alk-Abello, INC | $13.43 | 2019 | |
| United Therapeutics Corporation | $12.88 | 2023 | Tyvaso, Orenitram |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arthur Hammer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.